Mirum Pharmaceuticals (MIRM) Competitors $72.71 -0.24 (-0.33%) As of 01:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MIRM vs. RDY, ASND, VTRS, ROIV, QGEN, ELAN, BBIO, MRNA, VRNA, and RVMDShould you be buying Mirum Pharmaceuticals stock or one of its competitors? The main competitors of Mirum Pharmaceuticals include Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Viatris (VTRS), Roivant Sciences (ROIV), QIAGEN (QGEN), Elanco Animal Health (ELAN), BridgeBio Pharma (BBIO), Moderna (MRNA), Verona Pharma PLC American Depositary Share (VRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry. Mirum Pharmaceuticals vs. Its Competitors Dr. Reddy's Laboratories Ascendis Pharma A/S Viatris Roivant Sciences QIAGEN Elanco Animal Health BridgeBio Pharma Moderna Verona Pharma PLC American Depositary Share Revolution Medicines Dr. Reddy's Laboratories (NYSE:RDY) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Does the media prefer RDY or MIRM? In the previous week, Dr. Reddy's Laboratories and Dr. Reddy's Laboratories both had 1 articles in the media. Dr. Reddy's Laboratories' average media sentiment score of 1.86 beat Mirum Pharmaceuticals' score of 0.92 indicating that Dr. Reddy's Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dr. Reddy's Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Mirum Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, RDY or MIRM? Dr. Reddy's Laboratories has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Which has stronger valuation and earnings, RDY or MIRM? Dr. Reddy's Laboratories has higher revenue and earnings than Mirum Pharmaceuticals. Mirum Pharmaceuticals is trading at a lower price-to-earnings ratio than Dr. Reddy's Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDr. Reddy's Laboratories$334.26B0.04$663M$0.6621.42Mirum Pharmaceuticals$336.89M10.84-$87.94M-$1.21-60.09 Do insiders & institutionals hold more shares of RDY or MIRM? 3.8% of Dr. Reddy's Laboratories shares are owned by institutional investors. 2.0% of Dr. Reddy's Laboratories shares are owned by company insiders. Comparatively, 22.9% of Mirum Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts recommend RDY or MIRM? Dr. Reddy's Laboratories currently has a consensus target price of $16.95, suggesting a potential upside of 19.92%. Mirum Pharmaceuticals has a consensus target price of $76.50, suggesting a potential upside of 5.21%. Given Dr. Reddy's Laboratories' higher probable upside, equities analysts clearly believe Dr. Reddy's Laboratories is more favorable than Mirum Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Reddy's Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83Mirum Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 3.00 Is RDY or MIRM more profitable? Dr. Reddy's Laboratories has a net margin of 16.99% compared to Mirum Pharmaceuticals' net margin of -13.65%. Dr. Reddy's Laboratories' return on equity of 17.25% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Dr. Reddy's Laboratories16.99% 17.25% 11.63% Mirum Pharmaceuticals -13.65%-24.76%-8.50% SummaryDr. Reddy's Laboratories beats Mirum Pharmaceuticals on 10 of the 16 factors compared between the two stocks. Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MIRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRM vs. The Competition Export to ExcelMetricMirum PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.64B$3.35B$6.11B$10.62BDividend YieldN/A2.28%5.66%4.70%P/E Ratio-59.8722.0785.7027.10Price / Sales10.84266.13528.36205.33Price / CashN/A46.3226.3031.12Price / Book15.479.9512.876.67Net Income-$87.94M-$52.35M$3.30B$275.95M7 Day Performance-0.19%5.81%4.10%3.05%1 Month Performance-4.40%11.46%7.37%10.44%1 Year Performance85.20%24.82%75.42%33.51% Mirum Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRMMirum Pharmaceuticals3.4499 of 5 stars$72.71-0.3%$76.50+5.2%+85.8%$3.64B$336.89M-59.87140RDYDr. Reddy's Laboratories3.2826 of 5 stars$13.96-1.9%$16.95+21.5%-9.5%$11.87B$334.26B21.1427,811Positive NewsASNDAscendis Pharma A/S2.9956 of 5 stars$191.60-0.2%$244.36+27.5%+43.0%$11.83B$393.54M-37.131,017VTRSViatris1.1631 of 5 stars$9.62+1.1%$10.40+8.1%-12.1%$11.10B$14.74B-3.3232,000ROIVRoivant Sciences3.4279 of 5 stars$15.10-0.5%$19.94+32.0%+42.1%$10.36B$23.23M-21.57860QGENQIAGEN4.4621 of 5 stars$43.880.0%$49.69+13.2%+10.5%$9.76B$1.98B25.935,765Analyst DowngradeELANElanco Animal Health2.5065 of 5 stars$19.63+0.1%$18.33-6.6%+40.8%$9.74B$4.44B22.829,000BBIOBridgeBio Pharma4.1948 of 5 stars$51.96+3.8%$63.94+23.1%+109.5%$9.57B$221.90M-12.70400MRNAModerna4.3419 of 5 stars$25.33+3.4%$41.81+65.1%-52.7%$9.53B$3.24B-3.365,800VRNAVerona Pharma PLC American Depositary Share1.9284 of 5 stars$106.61-0.1%$109.00+2.2%+233.6%$9.20B$42.28M-107.6930Positive NewsRVMDRevolution Medicines4.2981 of 5 stars$46.07+4.9%$74.64+62.0%-1.3%$8.21B$11.58M-10.24250 Related Companies and Tools Related Companies Dr. Reddy's Laboratories Competitors Ascendis Pharma A/S Competitors Viatris Competitors Roivant Sciences Competitors QIAGEN Competitors Elanco Animal Health Competitors BridgeBio Pharma Competitors Moderna Competitors Verona Pharma PLC American Depositary Share Competitors Revolution Medicines Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRM) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
